Jorge R Kizer1, David Benkeser2, Alice M Arnold2, Joachim H Ix3, Kenneth J Mukamal4, Luc Djousse5, Russell P Tracy6, David S Siscovick7, Bruce M Psaty8, Susan J Zieman9. 1. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: jorge.kizer@einstein.yu.edu. 2. Department of Biostatistics, University of Washington, Seattle, WA, USA. 3. Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA; Division of Nephrology, Department of Medicine, San Diego, CA, USA; Division of Preventive Medicine, Department of Family and Preventive Medicine, University of California San Diego, San Diego, CA, USA. 4. Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. 5. Harvard Medical School, Boston, MA, USA; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 6. Department of Pathology, University of Vermont, Colchester, VT, USA; Department of Biochemistry, University of Vermont, Colchester, VT, USA. 7. Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA; Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, WA, USA. 8. Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA; Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Health Services, University of Washington, Seattle, WA, USA; Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA. 9. Division of Geriatrics and Clinical Gerontology, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: Advanced glycation/glycoxidation endproducts (AGEs) accumulate in settings of increased oxidative stress--such as diabetes, chronic kidney disease and aging--where they promote vascular stiffness and atherogenesis, but the prospective association between AGEs and cardiovascular events in elders has not been previously examined. METHODS: To test the hypothesis that circulating levels of N(ɛ)-carboxymethyl-lysine (CML), a major AGE, increase the risk of incident coronary heart disease and stroke in older adults, we measured serum CML by immunoassay in 2111 individuals free of prevalent cardiovascular disease participating in a population-based study of U.S. adults ages 65 and older. RESULTS: During median follow-up of 9.1 years, 625 cardiovascular events occurred. CML was positively associated with incident cardiovascular events after adjustment for age, sex, race, systolic blood pressure, anti-hypertensive treatment, diabetes, smoking status, triglycerides, albumin, and self-reported health status (hazard ratio [HR] per SD [0.99 pmol/l] increase=1.11, 95% confidence interval [CI]=1.03-1.19). This association was not materially attenuated by additional adjustment for C-reactive protein, estimated glomerular filtration rate (eGFR), and urine albumin/creatinine ratio. Findings were similar for the component endpoints of coronary heart disease and stroke. CONCLUSIONS: In this large older cohort, CML was associated with an increased risk of cardiovascular events independent of a wide array of potential confounders and mediators. Although the moderate association limits CML's value for risk prediction, these community-based findings provide support for clinical trials to test AGE-lowering therapies for cardiovascular prevention in this population.
BACKGROUND: Advanced glycation/glycoxidation endproducts (AGEs) accumulate in settings of increased oxidative stress--such as diabetes, chronic kidney disease and aging--where they promote vascular stiffness and atherogenesis, but the prospective association between AGEs and cardiovascular events in elders has not been previously examined. METHODS: To test the hypothesis that circulating levels of N(ɛ)-carboxymethyl-lysine (CML), a major AGE, increase the risk of incident coronary heart disease and stroke in older adults, we measured serum CML by immunoassay in 2111 individuals free of prevalent cardiovascular disease participating in a population-based study of U.S. adults ages 65 and older. RESULTS: During median follow-up of 9.1 years, 625 cardiovascular events occurred. CML was positively associated with incident cardiovascular events after adjustment for age, sex, race, systolic blood pressure, anti-hypertensive treatment, diabetes, smoking status, triglycerides, albumin, and self-reported health status (hazard ratio [HR] per SD [0.99 pmol/l] increase=1.11, 95% confidence interval [CI]=1.03-1.19). This association was not materially attenuated by additional adjustment for C-reactive protein, estimated glomerular filtration rate (eGFR), and urine albumin/creatinine ratio. Findings were similar for the component endpoints of coronary heart disease and stroke. CONCLUSIONS: In this large older cohort, CML was associated with an increased risk of cardiovascular events independent of a wide array of potential confounders and mediators. Although the moderate association limits CML's value for risk prediction, these community-based findings provide support for clinical trials to test AGE-lowering therapies for cardiovascular prevention in this population.
Authors: Jorge R Kizer; Mary L Biggs; Joachim H Ix; Kenneth J Mukamal; Susan J Zieman; Ian H de Boer; Dariush Mozaffarian; Joshua I Barzilay; Elsa S Strotmeyer; Jose A Luchsinger; Mitchell S V Elkind; W T Longstreth; Lewis H Kuller; David S Siscovick Journal: Am J Epidemiol Date: 2010-12-01 Impact factor: 4.897
Authors: Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati Journal: N Engl J Med Date: 2010-03-04 Impact factor: 91.245
Authors: Helen Vlassara; Jaime Uribarri; Weijing Cai; Susan Goodman; Renata Pyzik; James Post; Fabrizio Grosjean; Mark Woodward; Gary E Striker Journal: Clin J Am Soc Nephrol Date: 2012-03-29 Impact factor: 8.237
Authors: Richard D Semba; Stefania Bandinelli; Kai Sun; Jack M Guralnik; Luigi Ferrucci Journal: J Am Geriatr Soc Date: 2009-08-13 Impact factor: 5.562
Authors: Johanna W Nin; Anders Jorsal; Isabel Ferreira; Casper G Schalkwijk; Martin H Prins; Hans-Henrik Parving; Lise Tarnow; Peter Rossing; Coen D Stehouwer Journal: Diabetes Care Date: 2011-02 Impact factor: 19.112
Authors: Paul J Beisswenger; Scott K Howell; Gregory B Russell; Michael E Miller; Stephen S Rich; Michael Mauer Journal: Diabetes Care Date: 2013-06-18 Impact factor: 19.112
Authors: Liang Chen; Zhigang Duan; Lesley Tinker; Haleh Sangi-Haghpeykar; Howard Strickler; Gloria Y F Ho; Marc J Gunter; Thomas Rohan; Craig Logsdon; Donna L White; Kathryn Royse; Hashem B El-Serag; Li Jiao Journal: Cancer Epidemiol Date: 2016-04-18 Impact factor: 2.984
Authors: Shaojun Yang; Yi-Hua Jan; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin Journal: Chem Res Toxicol Date: 2017-06-26 Impact factor: 3.739
Authors: Stephanie J Loomis; Yuan Chen; David B Sacks; Eric S Christenson; Robert H Christenson; Casey M Rebholz; Elizabeth Selvin Journal: Clin Chem Date: 2017-03-09 Impact factor: 8.327
Authors: V C Luft; B B Duncan; M I Schmidt; L E Chambless; J S Pankow; R C Hoogeveen; D J Couper; G Heiss Journal: Diabet Med Date: 2015-10-06 Impact factor: 4.359
Authors: Peter D Ahiawodzi; Richard A Kerber; Kira C Taylor; Frank D Groves; Elizabeth O'Brien; Joachim H Ix; Jorge R Kizer; Luc Djoussé; Russell P Tracy; Anne B Newman; David S Siscovick; John Robbins; Kenneth Mukamal Journal: Biomarkers Date: 2017-01-25 Impact factor: 2.658
Authors: Parveen K Garg; Mary L Biggs; Joshua Barzilay; Luc Djousse; Calvin Hirsch; Joachim H Ix; Jorge R Kizer; Russell P Tracy; Anne B Newman; David S Siscovick; Kenneth J Mukamal Journal: Diab Vasc Dis Res Date: 2019-05-08 Impact factor: 3.291
Authors: Rajkishor Nishad; Vazeeha Tahaseen; Rajesh Kavvuri; Manga Motrapu; Ashish K Singh; Kiranmayi Peddi; Anil K Pasupulati Journal: Front Med (Lausanne) Date: 2021-07-01
Authors: Vincent M Monnier; Wanjie Sun; Xiaoyu Gao; David R Sell; Patricia A Cleary; John M Lachin; Saul Genuth Journal: Cardiovasc Diabetol Date: 2015-09-05 Impact factor: 9.951
Authors: S Piras; A L Furfaro; C Domenicotti; N Traverso; U M Marinari; M A Pronzato; M Nitti Journal: Oxid Med Cell Longev Date: 2016-05-25 Impact factor: 6.543